Synthesis of 2-hydroxy-N,N-dimethyl-3-[[2-[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-l]aminobenzamide
申请人:Schering Corporation
公开号:US20040209946A1
公开(公告)日:2004-10-21
Disclosed is a process for making the compound of formula I:
1
using the compounds of formulas II, Q, and XI or XII:
2
wherein A is selected from the group consisting of Br, Cl and I (with Br being preferred); and R represents (C
1
-C
10
)alkyl. Also disclosed are intermediate compounds that are made in the disclosed process.
SYNTHESIS OF 2-HYDROXY-N,N-DIMETHYL-3-[[2-[[1(R)-(5-METHYL-2-FURANYL)PROPYL]AMINO]-3,4-DIOXO-1-CYCLOBUTEN-1-YL]AMINO]BENZAMIDE
申请人:Yin Jianguo
公开号:US20090048458A1
公开(公告)日:2009-02-19
Disclosed is a process for making the compound of formula I:
using the compounds of formulas II, Q, and XI or XII:
wherein A is selected from the group consisting of Br, Cl and I (with Br being preferred); and R represents (C
1
-C
10
)alkyl. Also disclosed are intermediate compounds that are made in the disclosed process.
The present invention relates to compounds of formula (I) with the substituents as defined herein, and uses thereof.
本发明涉及具有公式(I)中所定义的取代基的化合物及其用途。
CXC-chemokine receptor ligands
申请人:Novartis AG
公开号:US08183281B2
公开(公告)日:2012-05-22
The present invention relates to compounds of formula (I) with the substituents as defined herein, and uses thereof.
本发明涉及公式(I)的化合物,其取代基如此定义,并且其用途。
Synthesis of 2-Hydroxy-N,N-Dimethyl-3-[[2-[1(r) - (5-Methyl-2-Furanyl) Propyl] -3, 4-Dioxo-1-Cyclobuten-1-Yl]amino] Benzamide
申请人:Schering Corporation
公开号:EP2168956A2
公开(公告)日:2010-03-31
Disclosed is a process for making a compound of the formula:
comprising converting the compound of formula II
to a compound of formula IV, wherein A is selected from the group consisting of Br, Cl and I.
本发明公开了一种制造式化合物的工艺:
包括将式 II 的化合物
转化为式 IV 的化合物,其中 A 选自由 Br、Cl 和 I 组成的组。